Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

The Th9 axis reduces oxidative stress and promotes the survival of malignant T-cells in cutaneous T-cell lymphoma patients.

Kumar S, Dhamija B, Marathe S, Ghosh S, Dwivedi A, Karulkar A, Sharma N, Sengar M, Sridhar E, Bonda A, Thorat J, Tembhare P, Shet T, Gujral S, Bagal B, Laskar S, Jain H, Purwar R.

Mol Cancer Res. 2020 Jan 29. pii: molcanres.0894.2019. doi: 10.1158/1541-7786.MCR-19-0894. [Epub ahead of print]

PMID:
31996468
2.

CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia.

Gudapati P, Khanka T, Chatterjee G, Ghogale S, Badrinath Y, Deshpande N, Patil J, Narula G, Shetty D, Banavali S, Patkar NV, Gujral S, Subramanian PG, Tembhare PR.

Cytometry B Clin Cytom. 2020 Jan 16. doi: 10.1002/cyto.b.21866. [Epub ahead of print]

PMID:
31944572
3.

A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1.

Patkar N, Shaikh AF, Kakirde C, Nathany S, Ramesh H, Bhanshe P, Joshi S, Chaudhary S, Kannan S, Khizer SH, Chatterjee G, Tembhare P, Shetty D, Gokarn A, Punatkar S, Bonda A, Nayak L, Jain H, Khattry N, Bagal B, Sengar M, Gujral S, Subramanian P.

Blood Cancer J. 2019 Oct 1;9(10):79. doi: 10.1038/s41408-019-0244-2. No abstract available.

4.

Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World Context.

Patkar N, Kakirde C, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Deshpande N, Kadechkar S, Chatterjee G, Kannan S, Shetty D, Gokarn A, Punatkar S, Bonda A, Nayak L, Jain H, Bagal B, Menon H, Sengar M, Khizer SH, Khattry N, Tembhare P, Gujral S, Subramanian P.

Front Oncol. 2019 Jun 13;9:450. doi: 10.3389/fonc.2019.00450. eCollection 2019.

5.

A High-Sensitivity 10-Color Flow Cytometric Minimal Residual Disease Assay in B-Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2-in-106 and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients.

Tembhare PR, Subramanian Pg PG, Ghogale S, Chatterjee G, Patkar NV, Gupta A, Shukla R, Badrinath Y, Deshpande N, Narula G, Rodrigues P, Girase K, Dhaliwal D, Prasad M, Shetty D, Banavali S, Gujral S.

Cytometry B Clin Cytom. 2020 Jan;98(1):57-67. doi: 10.1002/cyto.b.21831. Epub 2019 Jun 14.

PMID:
31197916
6.

Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia.

Patkar N, Kodgule R, Kakirde C, Raval G, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Kadechkar S, Khizer SH, Kannan S, Shetty D, Gokarn A, Punatkar S, Jain H, Bagal B, Menon H, Sengar M, Khattry N, Tembhare P, Subramanian P, Gujral S.

Oncotarget. 2019 Jan 15;10(5):617. doi: 10.18632/oncotarget.26610. eCollection 2019 Jan 15.

7.

Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?

Scott SD, Fletcher M, Whitehouse H, Whitby L, Yuan C, Mazzucchelli S, Lin P, de Tute R, Dorwal P, Wallace PK, Tembhare P, Arroz M, Snowden JA, Chantry AD, Barnett D.

Cytometry B Clin Cytom. 2019 May;96(3):201-208. doi: 10.1002/cyto.b.21754. Epub 2018 Dec 19.

PMID:
30565840
8.

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia.

Patkar N, Kodgule R, Kakirde C, Raval G, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Kadechkar S, Khizer SH, Kannan S, Shetty D, Gokarn A, Punatkar S, Jain H, Bagal B, Menon H, Sengar M, Khattry N, Tembhare P, Subramanian P, Gujral S.

Oncotarget. 2018 Nov 27;9(93):36613-36624. doi: 10.18632/oncotarget.26400. eCollection 2018 Nov 27. Erratum in: Oncotarget. 2019 Jan 15;10(5):617.

9.

BRAFV600E mutation in hairy cell leukemia: A single-center experience.

Bibi A, Java S, Chaudhary S, Joshi S, Mascerhenas R, Rabade N, Tembhare P, Subramanian PG, Gujral S, Menon H, Khattry N, Sengar M, Bagal B, Jain H, Patkar N.

Indian J Pathol Microbiol. 2018 Oct-Dec;61(4):532-536. doi: 10.4103/IJPM.IJPM_484_16.

10.

Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit.

Khattry N, Laskar S, Sengar M, Rangarajan V, Shet T, Subramanian PG, Epari S, Bagal B, Goda JS, Agarwal A, Jain H, Tembhare P, Patkar N, Khanna N, Punatar S, Gokarn A, Shetty D, Jain H, Bonda A, Gota V, Hasan S, Kode J, Dutt S, Kulkarni S, Shetty N, Sable N, Deodhar J, Jadhav S, Pawaskar P, Mathew L, Menon H, Nair R, Kannan S, Chiplunkar S, Gujral S.

Indian J Cancer. 2018 Jan-Mar;55(1):9-15. doi: 10.4103/ijc.IJC_656_17.

11.

Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial Hospital.

Narula G, Prasad M, Jatia S, Subramanian PG, Patkar N, Tembhare P, Shetty D, Khanna N, Laskar S, Shet T, Epari S, Kembhavi S, Shah S, Qureshi S, Gujral S, Banavali SD.

Indian J Cancer. 2017 Oct-Dec;54(4):609-615. doi: 10.4103/ijc.IJC_487_17.

12.

Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India.

Rabade N, Subramanian PG, Kodgule R, Raval G, Joshi S, Chaudhary S, Mascarenhas R, Tembhare P, Gujral S, Patkar N.

Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):209-213. doi: 10.4103/IJPM.IJPM_223_17.

13.

Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiences.

Modkharkar S, Navale P, Amare PK, Chougule A, Patkar N, Tembhare P, Menon H, Sengar M, Khattry N, Banavali S, Arora B, Narula G, Laskar S, Khanna N, Muckaden MA, Rangarajan V, Agrawal A, Shet T, Epari S, Subramanian PG, Gujral S.

Indian J Pathol Microbiol. 2018 Jan-Mar;61(1):58-65. doi: 10.4103/IJPM.IJPM_56_17.

14.

Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India.

Rabade N, Raval G, Chaudhary S, Subramanian PG, Kodgule R, Joshi S, Tembhare P, Hasan SK, Jain H, Sengar M, Narula G, Banavali S, Kadam PA, Shetty D, Gujral S, Patkar N.

Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018002. doi: 10.4084/MJHID.2018.002. eCollection 2018.

15.

Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies.

Tembhare PR, Ghogale S, Tauro W, Badrinath Y, Deshpande N, Kedia S, Cherian K, Patkar NV, Chatterjee G, Gujral S, Subramanian PG.

Cytometry B Clin Cytom. 2018 May;94(3):509-519. doi: 10.1002/cyto.b.21619. Epub 2018 Jan 19.

16.

A Rare Extramedullary and Extralymphoid Presentation of Mixed Phenotypic Blastic Hematolymphoid Neoplasm: A Study of Two Cases.

Ghodke K, Tembhare P, Patkar N, Subramanian PG, Arora B, Gujral S.

Indian J Med Paediatr Oncol. 2017 Jul-Sep;38(3):394-397. doi: 10.4103/ijmpo.ijmpo_94_16.

17.

Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.

Chatterjee G, Gujral S, Subramanian PG, Tembhare PR.

Indian J Hematol Blood Transfus. 2017 Sep;33(3):303-315. doi: 10.1007/s12288-017-0822-z. Epub 2017 Apr 26. Review.

18.

An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemia.

Patkar N, Subramanian PG, Tembhare P, Mandalia S, Chaterjee G, Rabade N, Kodgule R, Chopra K, Bibi A, Joshi S, Chaudhary S, Mascerhenas R, Kadam-Amare P, Narula G, Arora B, Banavali S, Gujral S.

Indian J Pathol Microbiol. 2017 Apr-Jun;60(2):209-213. doi: 10.4103/IJPM.IJPM_466_16.

19.

Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma.

Salem DA, Korde N, Venzon DJ, Liewehr DJ, Maric I, Calvo KR, Braylan R, Tembhare PR, Yuan CM, Landgren CO, Stetler-Stevenson M.

Leuk Lymphoma. 2018 Jan;59(1):178-186. doi: 10.1080/10428194.2017.1321746. Epub 2017 May 25.

20.

Method for DNA Ploidy Analysis Along with Immunophenotyping for Rare Populations in a Sample using FxCycle Violet.

Tembhare P, Badrinath Y, Ghogale S, Subramanian PG.

Curr Protoc Cytom. 2017 Apr 3;80:6.38.1-6.38.15. doi: 10.1002/cpcy.15.

PMID:
28369766
21.

Biclonal chronic lymphocytic leukemia: A study of two cases and review of literature.

Ghodke KA, Patkar NV, Subramanian PG, Gujral S, Kadam PA, Tembhare PR.

Indian J Pathol Microbiol. 2017 Jan-Mar;60(1):84-86. doi: 10.4103/0377-4929.200019. Review.

22.

Immunogenetics of chronic lymphocytic leukemia.

Patkar N, Rabade N, Kadam PA, Mishra F, Muranjan A, Tembhare P, Chaudhary S, Joshi S, Jain H, Dangi U, Bagal B, Khattry N, Menon H, Gujral S, Sengar M, Subramanian PG.

Indian J Pathol Microbiol. 2017 Jan-Mar;60(1):38-42. doi: 10.4103/0377-4929.200051.

23.

Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000.

Tembhare PR, Ghogale S, Ghatwai N, Badrinath Y, Kunder N, Patkar NV, Bibi AR, Chatterjee G, Arora B, Narula G, Banawali S, Deshpande N, Amare P, Gujral S, Subramanian PG.

Cytometry B Clin Cytom. 2018 Jan;94(1):100-111. doi: 10.1002/cyto.b.21486. Epub 2016 Oct 27.

24.

Lymphoblastic leukemia with surface light chain restriction: A diagnostic dilemma.

Rabade N, Bibi A, Ghodke K, Patkar N, Tembhare P, Amare P, Subramanian PG, Gujral S.

Indian J Pathol Microbiol. 2016 Jul-Sep;59(3):410-2. doi: 10.4103/0377-4929.188129.

25.

'Childhood systemic mastocytosis associated with t (8; 21) (q22; q22) acute myeloid leukemia'.

Rabade N, Tembhare P, Patkar N, Amare P, Arora B, Subramanian PG, Gujral S.

Indian J Pathol Microbiol. 2016 Jul-Sep;59(3):407-9. doi: 10.4103/0377-4929.188140.

26.

Development of a cost-effective 'duplexed' real-time PCR assay for minimal residual disease monitoring of chronic myeloid leukemia using locked nucleic acid probes.

Patkar N, Joshi S, Chaudhary S, Mascerhenas R, Doshi H, Tembhare P, Gujral S, Subramanian PG.

Int J Lab Hematol. 2016 Dec;38(6):e102-e106. doi: 10.1111/ijlh.12541. Epub 2016 Jul 27. No abstract available.

PMID:
27461906
27.

Population pharmacokinetics of Reditux™, a biosimilar Rituximab, in diffuse large B-cell lymphoma.

Gota V, Karanam A, Rath S, Yadav A, Tembhare P, Subramanian P, Sengar M, Nair R, Menon H.

Cancer Chemother Pharmacol. 2016 Aug;78(2):353-9. doi: 10.1007/s00280-016-3083-x. Epub 2016 Jun 21.

PMID:
27329361
28.

CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.

Ghodke K, Bibi A, Rabade N, Patkar N, Subramanian PG, Kadam PA, Badrinath Y, Ghogale S, Gujral S, Tembhare P.

Cytometry B Clin Cytom. 2017 Jul;92(4):315-318. doi: 10.1002/cyto.b.21373. Epub 2016 Jun 8.

29.

Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance.

Patkar N, Ghodke K, Joshi S, Chaudhary S, Mascerhenas R, Dusseja S, Mahadik S, Gaware S, Tembhare P, Gujral S, Kabre S, Kadam-Amare P, Jain H, Dangi U, Bagal B, Khattry N, Sengar M, Arora B, Narula G, Banavali S, Menon H, Subramanian PG.

Leuk Lymphoma. 2016 Nov;57(11):2653-60. doi: 10.3109/10428194.2016.1157868. Epub 2016 Mar 21.

PMID:
26999421
30.

A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping.

Tembhare P, Badrinath Y, Ghogale S, Patkar N, Dhole N, Dalavi P, Kunder N, Kumar A, Gujral S, Subramanian PG.

Cytometry A. 2016 Mar;89(3):281-91. doi: 10.1002/cyto.a.22803. Epub 2015 Dec 15.

31.

Unusual immunophenotype of T-cell large granular lymphocytic leukemia: report of two cases.

Rabade N, Mansukhani D, Khodaiji S, Padte B, Bhave A, Tembhare P, Subramanian PG, Sehgal K.

Indian J Pathol Microbiol. 2015 Jan-Mar;58(1):108-12. doi: 10.4103/0377-4929.151204.

32.

MYD88 mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart.

Patkar N, Subramanian PG, Deshpande P, Ghodke K, Tembhare P, Mascarenhas R, Muranjan A, Chaudhary S, Bagal B, Gujral S, Sengar M, Menon H.

Leuk Lymphoma. 2015 Feb;56(2):420-5. doi: 10.3109/10428194.2014.924123. Epub 2014 Aug 4.

PMID:
24828863
33.

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma.

Korde N, Carlsten M, Lee MJ, Minter A, Tan E, Kwok M, Manasanch E, Bhutani M, Tageja N, Roschewski M, Zingone A, Costello R, Mulquin M, Zuchlinski D, Maric I, Calvo KR, Braylan R, Tembhare P, Yuan C, Stetler-Stevenson M, Trepel J, Childs R, Landgren O.

Haematologica. 2014 Jun;99(6):e81-3. doi: 10.3324/haematol.2013.103085. Epub 2014 Mar 21. No abstract available.

34.

Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases.

Tembhare PR, Yuan CM, Venzon D, Braylan R, Korde N, Manasanch E, Zuchlinsky D, Calvo K, Kurlander R, Bhutani M, Tageja N, Maric I, Mulquin M, Roschewski M, Kwok M, Liewehr D, Landgren O, Stetler-Stevenson M.

Leuk Res. 2014 Mar;38(3):371-6. doi: 10.1016/j.leukres.2013.12.007. Epub 2013 Dec 11.

35.

Quantification of expression of antigens targeted by antibody-based therapy in chronic lymphocytic leukemia.

Tembhare PR, Marti G, Wiestner A, Degheidy H, Farooqui M, Kreitman RJ, Jasper GA, Yuan CM, Liewehr D, Venzon D, Stetler-Stevenson M.

Am J Clin Pathol. 2013 Dec;140(6):813-8. doi: 10.1309/AJCPYFQ4XMGJD6TI.

36.

Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.

Shao H, Calvo KR, Grönborg M, Tembhare PR, Kreitman RJ, Stetler-Stevenson M, Yuan CM.

Leuk Res. 2013 Apr;37(4):401-409. doi: 10.1016/j.leukres.2012.11.021. Epub 2013 Jan 22.

37.

Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study.

Cherry BM, Korde N, Kwok M, Manasanch EE, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Maric I, Calvo KR, Braylan R, Stetler-Stevenson M, Yuan C, Tembhare P, Zingone A, Costello R, Roschewski MJ, Landgren O.

Leuk Lymphoma. 2013 Oct;54(10):2215-8. doi: 10.3109/10428194.2013.764419. Epub 2013 Jul 29.

PMID:
23311294
38.

Case study interpretation--Portland: Case 1. Hairy cell leukemia with CLL-like monoclonal B lymphocytosis.

Tembhare P, Yuan CM, Xi L, Marti G, Raffeld M, Stetler-Stevenson M.

Cytometry B Clin Cytom. 2012 May;82(3):177-9. doi: 10.1002/cyto.b.21012. Epub 2012 Mar 19. No abstract available.

39.

Flow cytometric immunophenotypic assessment of T-cell clonality by vβ repertoire analysis in fine-needle aspirates and cerebrospinal fluid.

Tembhare P, Yuan CM, Morris JC, Janik JE, Filie AC, Stetler-Stevenson M.

Am J Clin Pathol. 2012 Feb;137(2):220-6. doi: 10.1309/AJCPPT93VZMAREHK.

PMID:
22261447
40.

Antigenic drift in relapsed extramedullary multiple myeloma: plasma cells without CD38 expression.

Tembhare P, Yuan C, Korde N, Maric I, Landgren O.

Leuk Lymphoma. 2012 Apr;53(4):721-4. doi: 10.3109/10428194.2011.623257. Epub 2011 Nov 25. No abstract available.

41.

Immunophenotypic profile in acute infectious mononucleosis mimicking malignant lymphoproliferative disorder: a case report and review of literature.

Tembhare P, Ramani M, Syed K, Gupta AD.

Indian J Hematol Blood Transfus. 2010 Sep;26(3):118-21. doi: 10.1007/s12288-010-0041-3. Epub 2010 Sep 30.

42.

Immunophenotypic profile of plasma cell leukemia: a retrospective study in a reference cancer center in India and review of literature.

Tembhare PR, Subramanian PG, Sehgal K, Yajamanam B, Kumar A, Gadge V, Inamdar N, Gujral S.

Indian J Pathol Microbiol. 2011 Apr-Jun;54(2):294-8. doi: 10.4103/0377-4929.81603. Review.

43.

Flow cytometric immunophenotypic assessment of T-cell clonality by Vβ repertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy.

Tembhare P, Yuan CM, Xi L, Morris JC, Liewehr D, Venzon D, Janik JE, Raffeld M, Stetler-Stevenson M.

Am J Clin Pathol. 2011 Jun;135(6):890-900. doi: 10.1309/AJCPV2D1DDSGJDBW.

PMID:
21571962
44.

Diagnosis of hairy cell leukemia by flow cytometry.

Stetler-Stevenson M, Tembhare PR.

Leuk Lymphoma. 2011 Jun;52 Suppl 2:11-3. doi: 10.3109/10428194.2011.570820. Epub 2011 Apr 19. Review.

PMID:
21504292
45.

Flow cytometric analysis of erythrocytes in paroxysmal nocturnal hemoglobinuria reveals superiority of CD59 as a diagnostic marker compared to CD55.

Tembhare P, Ramani M, Syed K, Gupta AD.

Indian J Pathol Microbiol. 2010 Oct-Dec;53(4):699-703. doi: 10.4103/0377-4929.72042.

46.

Comparison of platelet counts by CellDyn Sapphire (Abbot Diagnostics), LH750 (Beckman Coulter), ReaPanThrombo immunoplatelet method (ReaMetrix), and the international flow reference method, in thrombocytopenic blood samples.

Sehgal K, Badrinath Y, Tembhare P, Subramanian PG, Talole S, Kumar A, Gadage V, Mahadik S, Ghogale S, Gujral S.

Cytometry B Clin Cytom. 2010 Jul;78(4):279-85. doi: 10.1002/cyto.b.20515.

47.

Hypergranular precursor B-cell acute lymphoblastic leukemia in a 16-year-old boy.

Tembhare PR, Subramanian PG, Sehgal K, Yajamanam B, Kumar A, Gujral S.

Indian J Pathol Microbiol. 2009 Jul-Sep;52(3):421-3. doi: 10.4103/0377-4929.55014.

48.

Exflagellated microgametes of Plasmodium vivax in human peripheral blood: a case report and review of the literature.

Tembhare P, Shirke S, Subramanian PG, Sehgal K, Gujral S.

Indian J Pathol Microbiol. 2009 Apr-Jun;52(2):252-4. Review.

49.

Intracytoplasmic antigen study by flow cytometry in hematolymphoid neoplasm.

Gujral S, Tembhare P, Badrinath Y, Subramanian PG, Kumar A, Sehgal K.

Indian J Pathol Microbiol. 2009 Apr-Jun;52(2):135-44. Review.

50.

Report of proceedings of the national meeting on "Guidelines for Immunophenotyping of Hematolymphoid Neoplasms by Flow Cytometry".

Gujral S, Subramanian PG, Patkar N, Badrinath Y, Kumar A, Tembhare P, Vazifdar A, Khodaiji S, Madkaikar M, Ghosh K, Yargop M, Dasgupta A.

Indian J Pathol Microbiol. 2008 Apr-Jun;51(2):161-6.

Supplemental Content

Loading ...
Support Center